Advisor Group Holdings, Inc. Ac Immune Sa Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.4 - $3.64 $2,400 - $3,640	-1,000 Reduced 33.33%	2,000 $6,000
Q2 2022 Aug 10, 2022	SELL	$2.35 - $4.47 $235 - $447	-100 Reduced 3.23%	3,000 $11,000
Q1 2022 May 04, 2022	SELL	$3.5 - $5.16 $3,850 - $5,676	-1,100 Reduced 26.19%	3,100 $12,000
Q3 2021 Nov 05, 2021	BUY	$6.2 - $8.34 $19,840 - $26,688	3,200 Added 320.0%	4,200 $28,000
Q1 2021 May 13, 2021	BUY	$5.32 - $8.96 $5,320 - $8,960	1,000 New	1,000 $8,000

28.2M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $296M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.